Atiq F, ODonnell J
Blood. 2024; 144(12):1247-1256.
PMID: 38728426
PMC: 11561537.
DOI: 10.1182/blood.2023021915.
Loscalzo J, Slayter H, Handin R, Farber D
Biophys J. 2009; 49(1):49-50.
PMID: 19431644
PMC: 1329572.
DOI: 10.1016/S0006-3495(86)83588-3.
Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K
Int J Hematol. 2002; 75(1):25-34.
PMID: 11843286
DOI: 10.1007/BF02981975.
Nachman R
West J Med. 1982; 136(4):318-25.
PMID: 6806985
PMC: 1273714.
Sola B, Avner P, Sultan Y, Jeanneau C, Maisonneuve P
Proc Natl Acad Sci U S A. 1982; 79(1):183-7.
PMID: 6798569
PMC: 345687.
DOI: 10.1073/pnas.79.1.183.
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri Z, ZIMMERMAN T
J Clin Invest. 1980; 65(6):1318-25.
PMID: 6773982
PMC: 371469.
DOI: 10.1172/JCI109795.
Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique.
Enayat M, Hill F
J Clin Pathol. 1983; 36(8):915-9.
PMID: 6409946
PMC: 498421.
DOI: 10.1136/jcp.36.8.915.
Structural analysis of factor VIII antigen in von Willebrand disease.
Nachman R, Jaffe E, Miller C, Brown W
Proc Natl Acad Sci U S A. 1980; 77(11):6832-6.
PMID: 6161373
PMC: 350384.
DOI: 10.1073/pnas.77.11.6832.
Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.
BOWIE E, Solberg Jr L, Fass D, Johnson C, Knutson G, Stewart M
J Clin Invest. 1986; 78(1):26-30.
PMID: 3088043
PMC: 329526.
DOI: 10.1172/JCI112560.
Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
Koedam J, Meijers J, Sixma J, Bouma B
J Clin Invest. 1988; 82(4):1236-43.
PMID: 2971673
PMC: 442674.
DOI: 10.1172/JCI113721.
Platelet hyperaggregation and increased plasma level of Von Willebrand factor in diabetics with retinopathy.
Bensoussan D, Levy Toledano S, Passa P, Caen J, Caniver J
Diabetologia. 1975; 11(4):307-12.
PMID: 1081963
DOI: 10.1007/BF00422396.
Presence of factor VIII-related antigen in blood platelets of patients with Von Willebrand's disease.
Bouma B, DeGraaf S, Sixma J, van Mourik J
Nature. 1975; 257(5526):510-12.
PMID: 1080838
PMC: 7086501.
DOI: 10.1038/257510a0.
Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.
Over J, Sixma J, Bruine M, Trieschnigg M, Vlooswijk R, Bouma B
J Clin Invest. 1978; 62(2):223-34.
PMID: 670391
PMC: 371757.
DOI: 10.1172/JCI109120.
Effect of dextran on factor VIII (antihemophilic factor) and platelet function.
Aberg M, Hedner U, Bergentz S
Ann Surg. 1979; 189(2):243-7.
PMID: 426556
PMC: 1397039.
DOI: 10.1097/00000658-197902000-00017.
Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.
COOPER H, Clemetson K, LUSCHER E
Proc Natl Acad Sci U S A. 1979; 76(3):1069-73.
PMID: 312498
PMC: 383190.
DOI: 10.1073/pnas.76.3.1069.
Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
Counts R, Paskell S, Elgee S
J Clin Invest. 1978; 62(3):702-9.
PMID: 308512
PMC: 371817.
DOI: 10.1172/JCI109178.
